NO875198L - Fastfase - analysemetode. - Google Patents
Fastfase - analysemetode.Info
- Publication number
- NO875198L NO875198L NO875198A NO875198A NO875198L NO 875198 L NO875198 L NO 875198L NO 875198 A NO875198 A NO 875198A NO 875198 A NO875198 A NO 875198A NO 875198 L NO875198 L NO 875198L
- Authority
- NO
- Norway
- Prior art keywords
- antigen
- solid phase
- specific antibody
- improved method
- determining
- Prior art date
Links
- 238000004458 analytical method Methods 0.000 title description 8
- 238000010532 solid phase synthesis reaction Methods 0.000 title description 6
- 239000000427 antigen Substances 0.000 claims description 137
- 102000036639 antigens Human genes 0.000 claims description 135
- 108091007433 antigens Proteins 0.000 claims description 135
- 239000007790 solid phase Substances 0.000 claims description 76
- 238000000034 method Methods 0.000 claims description 70
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 26
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 26
- 229960000187 tissue plasminogen activator Drugs 0.000 claims description 25
- 238000000576 coating method Methods 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 108060003951 Immunoglobulin Proteins 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 102000018358 immunoglobulin Human genes 0.000 claims description 6
- 239000012071 phase Substances 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 229940072221 immunoglobulins Drugs 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 3
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 239000004816 latex Substances 0.000 claims description 3
- 229920000126 latex Polymers 0.000 claims description 3
- 229920000193 polymethacrylate Polymers 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 241000598436 Human T-cell lymphotropic virus Species 0.000 claims description 2
- 239000000463 material Substances 0.000 claims 2
- 102000001938 Plasminogen Activators Human genes 0.000 claims 1
- 108010001014 Plasminogen Activators Proteins 0.000 claims 1
- 229940127126 plasminogen activator Drugs 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 239000000523 sample Substances 0.000 description 47
- 238000005259 measurement Methods 0.000 description 21
- 210000002381 plasma Anatomy 0.000 description 21
- 229920000136 polysorbate Polymers 0.000 description 20
- 239000002953 phosphate buffered saline Substances 0.000 description 18
- 238000002965 ELISA Methods 0.000 description 15
- 239000000872 buffer Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- 238000001514 detection method Methods 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 241000283707 Capra Species 0.000 description 6
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001900 immune effect Effects 0.000 description 5
- 230000020477 pH reduction Effects 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- 230000009871 nonspecific binding Effects 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000012556 adjustment buffer Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000036963 noncompetitive effect Effects 0.000 description 2
- 238000010979 pH adjustment Methods 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 238000004451 qualitative analysis Methods 0.000 description 2
- 239000007974 sodium acetate buffer Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 241000589968 Borrelia Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000016604 Lyme disease Diseases 0.000 description 1
- 101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013578 denaturing buffer Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- ZGSPNIOCEDOHGS-UHFFFAOYSA-L disodium [3-[2,3-di(octadeca-9,12-dienoyloxy)propoxy-oxidophosphoryl]oxy-2-hydroxypropyl] 2,3-di(octadeca-9,12-dienoyloxy)propyl phosphate Chemical compound [Na+].[Na+].CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COP([O-])(=O)OCC(O)COP([O-])(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC ZGSPNIOCEDOHGS-UHFFFAOYSA-L 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940043517 specific immunoglobulins Drugs 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/972—Plasminogen activators
- G01N2333/9726—Tissue plasminogen activator
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8601695A SE454465B (sv) | 1986-04-15 | 1986-04-15 | Non kompetitiv fast-fas immunanalys med kompensation for ospecifik adsorption |
| PCT/US1987/000876 WO1987006346A1 (en) | 1986-04-15 | 1987-04-15 | Solid phase analysis method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO875198D0 NO875198D0 (no) | 1987-12-14 |
| NO875198L true NO875198L (no) | 1987-12-14 |
Family
ID=20364187
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO875198A NO875198L (no) | 1986-04-15 | 1987-12-14 | Fastfase - analysemetode. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5169756A (ja) |
| EP (1) | EP0262217B1 (ja) |
| JP (1) | JPH0635977B2 (ja) |
| KR (1) | KR900005486B1 (ja) |
| AU (1) | AU588111B2 (ja) |
| DE (1) | DE3788402T2 (ja) |
| DK (1) | DK650387A (ja) |
| FI (1) | FI875422A0 (ja) |
| HU (1) | HUT56633A (ja) |
| MC (1) | MC1865A1 (ja) |
| NO (1) | NO875198L (ja) |
| OA (1) | OA08783A (ja) |
| RO (1) | RO105528B1 (ja) |
| SE (1) | SE454465B (ja) |
| WO (1) | WO1987006346A1 (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0339302B1 (en) * | 1988-04-04 | 1993-12-22 | Teijin Limited | Reagent system for immunologically assaying complex of human plasminogen activator inhibitor and human tissue plasminogen activator, and assay kit therefor |
| IT1226712B (it) * | 1988-08-05 | 1991-02-05 | Eniricerche Spa | Metodo immunoenzimatico elisa monopiastra con inibizione competitiva per la rivelazione di anticorpi antisporozoitari di plasmodium falciparum. |
| US5807752A (en) * | 1992-09-11 | 1998-09-15 | Boehringer Mannheim Corporation | Assay using an unblocked solid phase with immobilized analyte binding partner |
| US5753457A (en) * | 1993-06-28 | 1998-05-19 | Akzo Nobel N.V. | Quantification of active plasminogen-activator-inhibitor-type-1 |
| ATE245199T1 (de) * | 1994-05-20 | 2003-08-15 | Sinai School Medicine | Behandlung von influenzavirus-infektion unter verwendung von antiviralen acylierung/palmitylierung von hemagglutinin hemmen |
| US6946258B2 (en) * | 2002-03-04 | 2005-09-20 | Biologix Diagnostics, Llc | Rapid, immunochemical process for measuring thiopurine methyltransferase |
| US20050287616A1 (en) * | 2004-06-29 | 2005-12-29 | Gross Adam F | Method of assaying denaturation of proteins |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4294817A (en) * | 1977-11-25 | 1981-10-13 | International Diagnostic Technology, Inc. | Method of fluoro immunoassay |
| DE3206729A1 (de) * | 1982-02-25 | 1983-09-01 | Behringwerke Ag, 3550 Marburg | Immunologisches agglutinationsverfahren |
| US4595661A (en) * | 1983-11-18 | 1986-06-17 | Beckman Instruments, Inc. | Immunoassays and kits for use therein which include low affinity antibodies for reducing the hook effect |
| US4661445A (en) * | 1985-05-24 | 1987-04-28 | Saxinger W Carl | Competitive ELISA for the detection of HTLV-III antibodies |
| DK289686A (da) * | 1986-06-19 | 1987-12-20 | Immuntech As | Fremgangsmaade til fremstilling af overfladebaserede immunanalyser |
-
1986
- 1986-04-15 SE SE8601695A patent/SE454465B/sv not_active IP Right Cessation
-
1987
- 1987-04-15 WO PCT/US1987/000876 patent/WO1987006346A1/en active IP Right Grant
- 1987-04-15 HU HU872754A patent/HUT56633A/hu unknown
- 1987-04-15 DE DE87903129T patent/DE3788402T2/de not_active Expired - Fee Related
- 1987-04-15 AU AU73573/87A patent/AU588111B2/en not_active Ceased
- 1987-04-15 JP JP62502725A patent/JPH0635977B2/ja not_active Expired - Lifetime
- 1987-04-15 EP EP87903129A patent/EP0262217B1/en not_active Expired - Lifetime
- 1987-04-15 US US07/038,740 patent/US5169756A/en not_active Expired - Fee Related
- 1987-04-15 MC MC87US8700876D patent/MC1865A1/xx unknown
- 1987-04-15 KR KR1019870701191A patent/KR900005486B1/ko active IP Right Grant
- 1987-12-09 FI FI875422A patent/FI875422A0/fi not_active IP Right Cessation
- 1987-12-10 DK DK650387A patent/DK650387A/da not_active Application Discontinuation
- 1987-12-11 OA OA59239A patent/OA08783A/xx unknown
- 1987-12-14 RO RO130949A patent/RO105528B1/ro unknown
- 1987-12-14 NO NO875198A patent/NO875198L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO875198D0 (no) | 1987-12-14 |
| KR900005486B1 (ko) | 1990-07-30 |
| FI875422A (fi) | 1987-12-09 |
| DE3788402T2 (de) | 1994-05-11 |
| OA08783A (en) | 1989-03-31 |
| SE8601695L (sv) | 1987-10-16 |
| US5169756A (en) | 1992-12-08 |
| KR880701380A (ko) | 1988-07-26 |
| MC1865A1 (fr) | 1988-12-19 |
| FI875422A0 (fi) | 1987-12-09 |
| EP0262217B1 (en) | 1993-12-08 |
| DK650387A (da) | 1988-01-13 |
| EP0262217A1 (en) | 1988-04-06 |
| DK650387D0 (da) | 1987-12-10 |
| DE3788402D1 (de) | 1994-01-20 |
| JPH02500211A (ja) | 1990-01-25 |
| SE8601695D0 (sv) | 1986-04-15 |
| AU588111B2 (en) | 1989-09-07 |
| AU7357387A (en) | 1987-11-09 |
| RO105528B1 (ro) | 1995-10-01 |
| SE454465B (sv) | 1988-05-02 |
| JPH0635977B2 (ja) | 1994-05-11 |
| HUT56633A (en) | 1991-09-30 |
| WO1987006346A1 (en) | 1987-10-22 |
| EP0262217A4 (en) | 1989-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6441407B2 (ja) | 非特異的結合を減少させるためのイムノアッセイ方法及び試薬 | |
| EP0315364A2 (en) | Simultaneous immunoassay for the determination of antigens and antibodies | |
| KR19980703302A (ko) | 글루타치온 s-트랜스퍼라제의 하나 또는 그 이상의 아이소엔자임 검출에 기초한 장기 상태 평가를 위한 쾌속 검정법 | |
| NO875198L (no) | Fastfase - analysemetode. | |
| de Azevedo Neto et al. | Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in Sao Paulo, Brazil | |
| CN104204801A (zh) | 免疫分析方法及试剂 | |
| US5589344A (en) | Test kit and method for competitive specific binding assay | |
| JPH0580053A (ja) | ヒト子宮体癌細胞の免疫化学的検出方法 | |
| JPH03170058A (ja) | イムノアッセイ用試薬複合体 | |
| US7422864B2 (en) | Method for measuring oxidized LDL-CRP complex and measurement kit | |
| JPH11295311A (ja) | 抗体測定方法 | |
| WO2022054754A1 (ja) | 敗血症原因細菌の免疫学的分析方法及び該方法に用いるモノクローナル抗体 | |
| JPH11248703A (ja) | 遊離ハプテンの免疫学的測定法 | |
| WO2023068249A1 (ja) | Ｉ型コラーゲン架橋ｎ－テロペプチドの測定試薬、その調製方法、及びそれを用いた免疫測定方法 | |
| US5916757A (en) | Specific binding assay using enzyme inhibitor and anti-inhibitor antibodies | |
| AU2077588A (en) | A color-coded solid phase analysis method | |
| JPH06289020A (ja) | 歯槽骨由来タンパクの測定方法 | |
| JP4907399B2 (ja) | 血中腸型脂肪酸結合蛋白測定による急性腸炎の検出方法 | |
| WO2007119481A1 (ja) | 血中腸型脂肪酸結合蛋白測定による急性腸炎診断 | |
| JP2003028860A (ja) | チトクロムｃ測定によるｓｉｒｓにおける多臓器不全の検査試薬 | |
| Yukawa et al. | Sandwich capture enzyme immunoassay for water soluble blood group B substance in secretor saliva | |
| Trinick et al. | RECENT DEVELOPMENTS IN MEASURING URINARY CONSTITUENTS BY NONISOTOPIC IMMUNOASSAY TECHNIQUES | |
| Pannuti et al. | Salivary antibody detection in epidemiological surveys: a pilot study after a mass vaccination campaign against rubella in Slo Paulo, Brazil | |
| JPH11281644A (ja) | 肝疾患又は慢性関節リウマチの検出方法並びにこれらの疾患の診断キット | |
| JPS58151560A (ja) | ヒト尿カリクレイン測定用キツト |